2018 UK Hepatitis Diagnostic Testing Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
![](/report_cover/2215/uk-hepatitis-diagnostic-testing-market-2021_en.gif)
Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.
The report presents a detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed.
The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:
Contains 241 pages and 14 tables
The report presents a detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed.
The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:
- Hospitals
- Commercial/Private Labs
- Blood Banks
- Public Health Labs
Contains 241 pages and 14 tables
1. INTRODUCTION
2. HEPATITIS WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Hepatitis A
C. Hepatitis B
D. Hepatitis C
Classification
Transmission of Infection
Occupational Hazards
Acute Hepatitis
Diagnosis of Acute Infection
Chronic Hepatitis
HCV and Other Chronic Liver Diseases
Alcoholic Liver Disease
Hepatitis B Coinfection
Cirrhosis and Hepatocellular Carcinoma
Diagnostic Tests
Possible Indications for HCV RNA Testing
Conclusions and Future Direction
E. Hepatitis D
Historical Perspective
Epidemiology
HBVHDV 'Coinfection' vs. 'Superinfection'
Methods of Detecting HDV
Prevention
F. Hepatitis E
Background
Prevalence of the Disease
Diagnostic Tests
Epidemiologic Serosurveys
Serologic CrossReactivity
G. Hepatitis G
Vaccines and Drugs
H. Review of Leading Analyzers Marketed by: Abbott, Beckman Coulter/Danaher, BioMerieux, OrthoClinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
I. EMERGING DIAGNOSTIC TECHNOLOGIES
1. MOLECULAR DIAGNOSTICS
2. MONOCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. DIFFERENTIAL LIGHT SCATTERING
5. INFORMATION TECHNOLOGY
6. ARTIFICIAL INTELLIGENCE
7. LIPOSOMES
8. FLOW CYTOMETRY
9. CHROMATOGRAPHY
10. DIAGNOSTIC IMAGING
11. GEL MICRODROPLETS
12. OTHER
8. U.K.: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
10. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION
11. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
12. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
BioRad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enz-Biochem
Fujirebio
Grifols
Hologic/GenProbe
ID Biomedical/GSK
Kreatech/Leica
Lonza
OrthoClinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Therm-Fisher
Wallac/PE
Wako
2. HEPATITIS WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Hepatitis A
C. Hepatitis B
D. Hepatitis C
Classification
Transmission of Infection
Occupational Hazards
Acute Hepatitis
Diagnosis of Acute Infection
Chronic Hepatitis
HCV and Other Chronic Liver Diseases
Alcoholic Liver Disease
Hepatitis B Coinfection
Cirrhosis and Hepatocellular Carcinoma
Diagnostic Tests
Possible Indications for HCV RNA Testing
Conclusions and Future Direction
E. Hepatitis D
Historical Perspective
Epidemiology
HBVHDV 'Coinfection' vs. 'Superinfection'
Methods of Detecting HDV
Prevention
F. Hepatitis E
Background
Prevalence of the Disease
Diagnostic Tests
Epidemiologic Serosurveys
Serologic CrossReactivity
G. Hepatitis G
Vaccines and Drugs
H. Review of Leading Analyzers Marketed by: Abbott, Beckman Coulter/Danaher, BioMerieux, OrthoClinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
I. EMERGING DIAGNOSTIC TECHNOLOGIES
1. MOLECULAR DIAGNOSTICS
2. MONOCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. DIFFERENTIAL LIGHT SCATTERING
5. INFORMATION TECHNOLOGY
6. ARTIFICIAL INTELLIGENCE
7. LIPOSOMES
8. FLOW CYTOMETRY
9. CHROMATOGRAPHY
10. DIAGNOSTIC IMAGING
11. GEL MICRODROPLETS
12. OTHER
8. U.K.: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
10. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION
11. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
12. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
BioRad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enz-Biochem
Fujirebio
Grifols
Hologic/GenProbe
ID Biomedical/GSK
Kreatech/Leica
Lonza
OrthoClinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Therm-Fisher
Wallac/PE
Wako
LIST OF TABLES
Major Companies Developing or Marketing Hepatitis Tests
U.K. HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Hbs Ag Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. AntiHBc Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. AntiHBs Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. AntiHAV Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. HBc Ag Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. HBe Ag Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Hepatitis Testing Market Diagnostics Sales by Major Supplier
U.K. Hepatitis C Testing Market Diagnostics Sales by Major Supplier
Major Companies Developing or Marketing Hepatitis Tests
U.K. HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Hbs Ag Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. AntiHBc Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. AntiHBs Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. AntiHAV Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. HBc Ag Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. HBe Ag Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Hepatitis Testing Market Diagnostics Sales by Major Supplier
U.K. Hepatitis C Testing Market Diagnostics Sales by Major Supplier